The Medical Cup Electrodes industry trends over the past 18 months have been shaped by a wave of consolidation and product innovation. In March 2024, Natus Medical acquired CerebralDx to fold high-density cup electrode arrays into its neurodiagnostic suite, accelerating hospital penetration across North America. Shortly after, Ambu A/S launched the Ambuยฎ NeuroCup ECO, a silver/silver-chloride disposable electrode produced on a 100 % recyclable polymer, anticipated to cut setup time by 35 % and align with ASCsโ push toward single-use sustainability. Regulatory momentum also shifted when the FDA reclassified non-invasive scalp cup electrodes from Class II to a special controls pathway in late 2023, trimming 510(k) review by ~45 days and prompting start-ups such as Synaptix (seed round, $9 M, Q1 24) to enter with AI-enhanced montage software. Meanwhile, European HTA bodies are favoring hybrid EEG/fNIRS cup systems, driving partnerships like g.tec medical and TU Eindhoven to co-develop dry-contact gel-free cups aimed at long-duration ICU monitoring. Collectively, these moves signal a pivot toward disposable, eco-friendly, multi-modal electrodes designed for outpatient and home-based neurocare.